These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2393335)

  • 1. [The electroretinogram and visual evoked potentials in patients with Parkinson's disease].
    Burguera JA; Vilela C; Traba A; Ameave Y; Vallet M
    Arch Neurobiol (Madr); 1990; 53(1):1-7. PubMed ID: 2393335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects.
    Nightingale S; Mitchell KW; Howe JW
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1280-7. PubMed ID: 3794734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease. Clinical and electrophysiological evaluation.
    Al-Bunyan MA
    Saudi Med J; 2000 Jan; 21(1):72-5. PubMed ID: 11533754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transient and steady-state electroretinograms and visual evoked potentials to pattern and uniform-field stimulation in humans].
    Nakayama M
    Fukuoka Igaku Zasshi; 1994 Jul; 85(7):225-34. PubMed ID: 8070753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy?
    Delalande I; Hache JC; Forzy G; Bughin M; Benhadjali J; Destée A
    Mov Disord; 1998 May; 13(3):446-52. PubMed ID: 9613735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials.
    Peppe A; Stanzione P; Pierelli F; De Angelis D; Pierantozzi M; Bernardi G
    Neurology; 1995 Jun; 45(6):1144-8. PubMed ID: 7783879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of levodopa plus carbidopa on evoked potentials in Parkinson's disease.
    Cosi V; Romani A; Callieco R; Zerbi F
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):603-9. PubMed ID: 6712828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?
    Katz B; Rimmer S; Iragui V; Katzman R
    Ann Neurol; 1989 Aug; 26(2):221-5. PubMed ID: 2774509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatosensory, motor and special visual evoked potentials to single and double stimulation in "Parkinson's disease" an early diagnostic test?
    Jörg J; Gerhard H
    J Neural Transm Suppl; 1987; 25():81-8. PubMed ID: 3480940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased dopamine in the retinas of patients with Parkinson's disease.
    Harnois C; Di Paolo T
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2473-5. PubMed ID: 2243012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of central motor functions using magnetic stimulation in Parkinson's disease.
    Diószeghy P; Hidasi E; Mechler F
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):101-5. PubMed ID: 10207679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotrichosis with juvenile macular dystrophy: clinical and electrophysiological assessment of visual function.
    Leibu R; Jermans A; Hatim G; Miller B; Sprecher E; Perlman I
    Ophthalmology; 2006 May; 113(5):841-7.e3. PubMed ID: 16650681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory evoked potentials (AEPs), early (BAEPs) and long latency components (LLCs) in Parkinson's disease: a 12 month follow-up study.
    Bindi A; Russo G; Benvenuti F; Bandinelli S; Ferrucci L; Rossi L
    Riv Neurol; 1987; 57(4):245-50. PubMed ID: 3685783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value of electroretinographic tests in Parkinson's disease (author's transl)].
    Cavallacci G; Perossini M
    J Fr Ophtalmol; 1979 Dec; 2(12):705-8. PubMed ID: 536573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomy and physiology of visual evoked potentials and electroretinograms.
    Celesia GG
    Neurol Clin; 1988 Nov; 6(4):657-79. PubMed ID: 3070333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.